Overview
Join our experienced 340B team for an audience-led, open forum Q&A session to address the long-awaited Genesis HealthCare, Inc. v. Becerra decision. While the Genesis case is broadly viewed as a win for 340B-eligible providers, many questions remain, including:
- How could the court’s opinion apply to entities other than Genesis?
- How might 340B-eligible providers expand their 340B programs while remaining in compliance?
- What does the court’s opinion mean about the Health Resources and Services Administration’s authority to interpret and enforce the 340B statute?
CASE OVERVIEW
Earlier this month, a federal court in South Carolina issued a long-awaited decision in the case of Genesis HealthCare, Inc. v. Becerra. In its decision, the court stated that a 340B-eligible provider can obtain 340B drugs to fill a prescription from another provider, as long as the individual receiving the drugs is also a patient of the 340B-eligible provider.
